Antihypertensive drugs in Japan [5]

Lancet

Volumn 357, Issue 9257, 2001, Pages 720-721

  Teramoto, Shinji ^a   Kume, Haruki ^b   Fukuchi, Yoshinosuke ^b  

^a INTERNATIONAL UNIVERSITY OF HEALTH AND WELFARE   (Japan)

^b JUNTENDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; SUBSTANCE P;

ASPIRATION PNEUMONIA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; COUGHING; DRUG EFFICACY; DRUG TOLERABILITY; ELDERLY CARE; HEART FAILURE; HUMAN; HYPERTENSION; JAPAN; LETTER; PRESCRIPTION; PRIORITY JOURNAL; RESPIRATORY FAILURE;

EID: 0035799135     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)71480-X     Document Type: Letter

References (5)

1. Effects of losartan compared with captopril on mortality in patients with symptomatic heart failure: Randomised trial - The Losartan Heart Failure Survival Study ELITE II
2. Comparison of losartan and captopril in ELITE II
3. ACE inhibitors and prevention of aspiration pneumonia in elderly hypertensives
4. Angiotensin-converting enzyme inhibitors, angiotensin II receptor antagonists, and symptomless dysphagia
5. Effects of angiotensin-converting enzyme (ACE) inhibitors on spontaneous or stimulated generation of reactive oxygen species by bronchoalveolar lavage cells harvested from patients with or without chronic obstructive pulmonary disease